Asano AT - Search Results

1

Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.

Nagpal S, Thacher SM, Patel S, Friant S, Malhotra M, Shafer J, Krasinski G, Asano AT, Teng M, Duvic M, Chandraratna RA. Nagpal S, et al. Among authors: asano at. Cell Growth Differ. 1996 Dec;7(12):1783-91. Cell Growth Differ. 1996. PMID: 8959347

2

Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin.

Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA. Nagpal S, et al. Among authors: asano at. J Invest Dermatol. 1996 Feb;106(2):269-74. doi: 10.1111/1523-1747.ep12340668. J Invest Dermatol. 1996. PMID: 8601727 Free article.

3

Molecular mechanisms of tazarotene action in psoriasis.

Duvic M, Nagpal S, Asano AT, Chandraratna RA. Duvic M, et al. Among authors: asano at. J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S18-24. J Am Acad Dermatol. 1997. PMID: 9270552 Review.

4

The pathogenesis of psoriasis and the mechanism of action of tazarotene.

Duvic M, Asano AT, Hager C, Mays S. Duvic M, et al. Among authors: asano at. J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S129-33. doi: 10.1016/s0190-9622(98)70309-3. J Am Acad Dermatol. 1998. PMID: 9777790 Review.

5

Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.

Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Jackow CM, et al. Among authors: asano at. Blood. 1997 Jan 1;89(1):32-40. Blood. 1997. PMID: 8978274 Free article.

6

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.

7

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.

Zhou Z, Jardine MJ, Li Q, Neuen BL, Cannon CP, de Zeeuw D, Edwards R, Levin A, Mahaffey KW, Perkovic V, Neal B, Lindley RI; CREDENCE Trial Investigators*. Zhou Z, et al. Stroke. 2021 May;52(5):1545-1556. doi: 10.1161/STROKEAHA.120.031623. Epub 2021 Apr 20. Stroke. 2021. PMID: 33874750 Free PMC article. Clinical Trial.

8

Raloxifene promotes adipocyte differentiation of 3T3-L1 cells.

Murase Y, Kobayashi J, Nohara A, Asano A, Yamaaki N, Suzuki K, Sato H, Mabuchi H. Murase Y, et al. Eur J Pharmacol. 2006 May 24;538(1-3):1-4. doi: 10.1016/j.ejphar.2006.03.033. Epub 2006 Apr 27. Eur J Pharmacol. 2006. PMID: 16643890

9

Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men.

Kobayashi J, Kusunoki M, Murase Y, Kawashiri M, Higashikata T, Miwa K, Katsuda S, Takata M, Asano A, Nohara A, Inazu A, Mabuchi H. Kobayashi J, et al. Horm Metab Res. 2005 Aug;37(8):505-9. doi: 10.1055/s-2005-870318. Horm Metab Res. 2005. PMID: 16138264

10

Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes.

Murase Y, Kobayashi J, Asano A, Yamaaki N, Yonezawa K, Muramoto H, Mabuchi H. Murase Y, et al. Horm Metab Res. 2006 Feb;38(2):130-3. doi: 10.1055/s-2006-925140. Horm Metab Res. 2006. PMID: 16523415 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters